固形腫瘍検査の世界市場レポート 2024

固形腫瘍検査の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.1%の年間複合成長率（CAGR）で364億8,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、がんの有病率の増加、ヘルスケアインフラの拡大、AIおよびIoTベースの診断デバイスの出現、この分野における政府の取り組みの増加に起因すると考えられます。予測期間中に予想される主な動向には、診断ツールの進歩、ナノキャリアベースの治療法のイントロダクション、戦略的提携、次世代検査装置の開発などが含まれます。

固形腫瘍検査市場は、がんの罹患率の増加により成長すると予想されています。がんは、制御されない異常細胞の増殖と広がりを特徴とし、多くの場合固形腫瘍の形で発生し、依然として重大な健康上の懸念となっています。 固形腫瘍検査は、画像検査でがん細胞が検出される前であっても、がん細胞を検出する上で重要な役割を果たします。 2023年6月の時点で、疾病管理予防センターの報告書によると、2020年に米国で新たに1,603,844人ががんに罹患し、602,347人ががん関連で死亡したことが明らかになりました。これは、固形腫瘍検査市場の成長を推進する重要な要素です。

固形腫瘍検査市場の成長に顕著に貢献しているのは、医療費の増加です。医療サービスと診断に関連するすべての費用をカバーする医療支出は、顕著な増加を見せています。医療の増加とがん診断に対する補助的な償還政策が、固形腫瘍検査市場の重要な推進力となっています。メディケア・メディケイド・サービスセンター（CMS）が発表した2023年6月のデータによると、米国の国民医療支出（NHE）は2021年に4兆3,000億米ドルに達し、国内総生産（GDP）の18.3％を占めました。医療支出の大幅かつ継続的な増加により、固形腫瘍検査市場が牽引されると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 市場促進要因・市場抑制要因
  • 市場促進要因
  • 市場抑制要因
• 市場規模と成長実績、2018～2023年
• 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の固形腫瘍検査市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 遺伝子検査
• 従来型検査
• 世界の固形腫瘍検査市場、がんの種類別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 乳がん
• 肺がん
• 結腸直腸がん
• 前立腺がん
• 子宮頸がん
• 世界の固形腫瘍検査市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 臨床
• 研究
• 世界の固形腫瘍検査市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 製薬会社・バイオテクノロジー会社
• 受託研究機関
• 学術研究機関

第7章 地域および国の分析

• 世界の固形腫瘍検査市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の固形腫瘍検査市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 固形腫瘍検査市場の競合情勢
• 固形腫瘍検査市場の企業プロファイル
  • Johnson &Johnson Ltd
  • Roche Diagnostics Corporation
  • Thermo Fisher Scientific Inc.
  • Abbott Molecular Inc.
  • Becton Dickinson And Company（BD）

第31章 その他の大手および革新的な企業

• Quest Diagnostics Incorporated
• Tosoh Corporation
• Agilent Technologies Inc.
• bioMerieux Inc.
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN GmbH
• Miltenyi Biotec GmbH
• Natera Inc.
• Myriad Genetics Inc.
• Novocure Inc.
• Invitae Corporation
• Guardant Health Inc.
• Foundation Medicine Inc.
• Epic Sciences Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Solid tumor testing involves diagnostic and molecular testing conducted on solid tumors, which are abnormal cell masses or growths that form in various body tissues. This type of testing is employed to detect cancer cells or cancer-related DNA in the blood of patients with solid tumors, even if the cancer is not yet visible on imaging tests.

The main types of solid tumor testing include genetic testing and conventional testing. Genetic testing is a medical test that examines an individual's DNA (genetic material) to identify changes or variations in genes, chromosomes, or proteins. This testing is applied in the treatment of various cancer types, including breast cancer, lung cancer, colorectal cancer, prostate cancer, and cervical cancer. Solid tumor testing serves various applications, including clinical and research purposes, and is utilized by diverse end-users such as hospitals, pharmaceutical and biotechnology companies, contract research organizations, and academic research institutions.

The solid tumor testing market research report is one of a series of new reports from The Business Research Company that provides solid tumor testing market statistics, including solid tumor testing industry global market size, regional shares, competitors with a solid tumor testing market share, detailed solid tumor testing market segments, market trends and opportunities, and any further data you may need to thrive in the solid tumor testing industry. This solid tumor testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The solid tumor testing market size has grown strongly in recent years. It will grow from $25.74 billion in 2023 to $27.78 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth observed in the historical period can be attributed to the rise of personalized or precision medicine, challenges associated with poor tumor-selective drug delivery, low therapeutic efficacy in traditional approaches, concerns related to unsustainable costs, and limitations of reductionist approaches in cancer chemotherapies.

The solid tumor testing market size is expected to see strong growth in the next few years. It will grow to $36.48 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The anticipated growth in the forecast period can be attributed to the increasing prevalence of cancer, the expansion of healthcare infrastructure, the emergence of AI and IoT-based diagnostic devices, and increasing government initiatives in the field. Key trends expected in the forecast period include advancements in diagnostic tools, the introduction of nanocarrier-based therapies, strategic collaborations, and the development of next-generation testing devices.

The solid tumor testing market is anticipated to experience growth, driven by an increase in the prevalence of cancer. Cancer, characterized by the uncontrolled growth and spread of abnormal cells, often in the form of solid tumors, remains a significant health concern. Solid tumor testing plays a crucial role in detecting cancer cells, even before they are visible on imaging tests. As of June 2023, a report from the Centers for Disease Control and Prevention revealed 1,603,844 new cancer cases and 602,347 cancer-related deaths in the US in 2020. The escalating prevalence of cancer, with 403 new cases and 144 cancer-related deaths reported for every 100,000 people, is a key factor propelling the growth of the solid tumor testing market.

A notable contributor to the growth of the solid tumor testing market is the increasing healthcare expenditure. Healthcare expenditure, covering all expenses related to health services and diagnostics, has witnessed a notable rise. The growth in healthcare expenditure and supportive reimbursement policies for cancer diagnostics are significant drivers for the solid tumor testing market. Data from June 2023, released by the Centers for Medicare & Medicaid Services (CMS), revealed that the national health expenditure (NHE) in the United States reached $4.3 trillion in 2021, accounting for 18.3% of the Gross Domestic Product (GDP). The substantial and continued growth in healthcare expenditure is expected to drive the solid tumor testing market.

A key trend in the solid tumor testing market is the emergence of innovative liquid biopsy test solutions. Major players in the market are actively engaged in developing liquid biopsy tests to enhance their market positions. In June 2020, NeoGenomics Inc., a US-based testing laboratory company, introduced a suite of three solid tumor liquid biopsy tests designed to detect cancer cells in the blood of patients with solid tumors. These tests offer non-invasive, early detection, and FDA-approved solutions, aiding in personalized treatment decisions with a quick turnaround time of seven days or fewer.

Companies in the solid tumor testing market are also focused on developing liquid biopsy platforms. These platforms utilize various technologies to analyze body fluids, typically blood, for cancer-related biomarkers. For instance, in January 2023, PrognomiQ, a US-based healthcare company, launched a multi-omics liquid biopsy platform. The platform is part of an ongoing prospective clinical program aiming to enroll 15,000 subjects, with a focus on leveraging multi-omics markers to distinguish between cancer and controls.

In June 2023, Quest Diagnostics, a US-based medical laboratory company, acquired Haystack Oncology Inc for $450 million. This acquisition is aimed at expanding access to liquid biopsy technology, strengthening research and development capabilities, and increasing market share in cancer diagnostics. Haystack Oncology Inc., an early-stage oncology company, specializes in developing solid tumor testing technology to improve outcomes for patients with cancer.

Major companies operating in the solid tumor testing market report are Johnson & Johnson Ltd, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Molecular Inc., Becton Dickinson And Company (BD), Quest Diagnostics Incorporated, Tosoh Corporation, Agilent Technologies Inc., bioMerieux Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Miltenyi Biotec GmbH, Natera Inc., Myriad Genetics Inc., Novocure Inc., Invitae Corporation, Guardant Health Inc., Foundation Medicine Inc., Epic Sciences Inc., Biocare Medical LLC, Agena Bioscience Inc., Caris Life Sciences Inc., 20/20 Gene Systems Inc., Grail Inc., Avant Diagnostics Inc., Genomic Testing Cooperative, Eutropics Pharmaceuticals Inc., Anixa Biosciences Inc., Cellular Biomedicine Group.

North America was the largest region in the solid tumor testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the solid tumor testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the solid tumor testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The solid tumor testing market consists of revenues earned by entities by providing molecular profiling, next-generation sequencing, immunohistochemistry, fluorescence in situ hybridization (FISH), and biomarker testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Solid Tumor Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on solid tumor testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for solid tumor testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The solid tumor testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Genetic Testing; Conventional Testing
• 2) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Cervical Cancer
• 3) By Application: Clinical; Research
• 4) By End-Users: Hospitals; Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic Research Institutions
• Companies Mentioned: Johnson & Johnson Ltd; Roche Diagnostics Corporation; Thermo Fisher Scientific Inc.; Abbott Molecular Inc.; Becton Dickinson And Company (BD)
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Solid Tumor Testing Market Characteristics

3. Solid Tumor Testing Market Trends And Strategies

4. Solid Tumor Testing Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Solid Tumor Testing Market Size and Growth

• 5.1. Global Solid Tumor Testing Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Solid Tumor Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Solid Tumor Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Solid Tumor Testing Market Segmentation

• 6.1. Global Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Genetic Testing
• Conventional Testing
• 6.2. Global Solid Tumor Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Cervical Cancer
• 6.3. Global Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Clinical
• Research
• 6.4. Global Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Pharmaceutical And Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutions

7. Solid Tumor Testing Market Regional And Country Analysis

• 7.1. Global Solid Tumor Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Solid Tumor Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Solid Tumor Testing Market

• 8.1. Asia-Pacific Solid Tumor Testing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Solid Tumor Testing Market

• 9.1. China Solid Tumor Testing Market Overview
• 9.2. China Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Solid Tumor Testing Market

• 10.1. India Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Solid Tumor Testing Market

• 11.1. Japan Solid Tumor Testing Market Overview
• 11.2. Japan Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Solid Tumor Testing Market

• 12.1. Australia Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Solid Tumor Testing Market

• 13.1. Indonesia Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Solid Tumor Testing Market

• 14.1. South Korea Solid Tumor Testing Market Overview
• 14.2. South Korea Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Solid Tumor Testing Market

• 15.1. Western Europe Solid Tumor Testing Market Overview
• 15.2. Western Europe Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Solid Tumor Testing Market

• 16.1. UK Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Solid Tumor Testing Market

• 17.1. Germany Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Solid Tumor Testing Market

• 18.1. France Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Solid Tumor Testing Market

• 19.1. Italy Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Solid Tumor Testing Market

• 20.1. Spain Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Solid Tumor Testing Market

• 21.1. Eastern Europe Solid Tumor Testing Market Overview
• 21.2. Eastern Europe Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Solid Tumor Testing Market

• 22.1. Russia Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Solid Tumor Testing Market

• 23.1. North America Solid Tumor Testing Market Overview
• 23.2. North America Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Solid Tumor Testing Market

• 24.1. USA Solid Tumor Testing Market Overview
• 24.2. USA Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Solid Tumor Testing Market

• 25.1. Canada Solid Tumor Testing Market Overview
• 25.2. Canada Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Solid Tumor Testing Market

• 26.1. South America Solid Tumor Testing Market Overview
• 26.2. South America Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Solid Tumor Testing Market

• 27.1. Brazil Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Solid Tumor Testing Market

• 28.1. Middle East Solid Tumor Testing Market Overview
• 28.2. Middle East Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Solid Tumor Testing Market

• 29.1. Africa Solid Tumor Testing Market Overview
• 29.2. Africa Solid Tumor Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Solid Tumor Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Solid Tumor Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Solid Tumor Testing Market Competitive Landscape And Company Profiles

• 30.1. Solid Tumor Testing Market Competitive Landscape
• 30.2. Solid Tumor Testing Market Company Profiles
  • 30.2.1. Johnson & Johnson Ltd
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Roche Diagnostics Corporation
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Thermo Fisher Scientific Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Abbott Molecular Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Becton Dickinson And Company (BD)
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Solid Tumor Testing Market Other Major And Innovative Companies

• 31.1. Quest Diagnostics Incorporated
• 31.2. Tosoh Corporation
• 31.3. Agilent Technologies Inc.
• 31.4. bioMerieux Inc.
• 31.5. Beckman Coulter Inc.
• 31.6. Bio-Rad Laboratories Inc.
• 31.7. QIAGEN GmbH
• 31.8. Miltenyi Biotec GmbH
• 31.9. Natera Inc.
• 31.10. Myriad Genetics Inc.
• 31.11. Novocure Inc.
• 31.12. Invitae Corporation
• 31.13. Guardant Health Inc.
• 31.14. Foundation Medicine Inc.
• 31.15. Epic Sciences Inc.

32. Global Solid Tumor Testing Market Competitive Benchmarking

33. Global Solid Tumor Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Solid Tumor Testing Market

35. Solid Tumor Testing Market Future Outlook and Potential Analysis

• 35.1 Solid Tumor Testing Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Solid Tumor Testing Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Solid Tumor Testing Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer